Company & Sponsor Intelligence

University Hospital, Limoges

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials3
Recruiting0
Completed1
Countries1

Therapeutic footprint

autismepilepsyother_psychiatry

Indexed studies

NCT02947880Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology
autism · France
PHASE2
NCT01979432The Cognitive and Cardiovascular Health in the Elderly Study
other_psychiatry · France
NA
NCT01374204Epilepsy-Associated Stigma
epilepsy · France
COMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →